Nav: Home

Family donates $1.25 million to Be The Match Foundation to support clinical trial candidates

January 17, 2017

MINNEAPOLIS--January 17, 2017--Every year, thousands of patients are diagnosed with blood cancers and other life-threatening diseases--and for many patients, treatments through clinical trials provide hope and potential cures. But for patients and their families, the process of finding and enrolling in clinical trials can be a challenging, frustrating process.

That is why the Carter family of Wayzata, Minn., has provided a generous $1.25 million donation to Be The Match Foundation®, the fundraising organization that supports Be The Match®, the world's leading nonprofit organization focused on saving lives through bone marrow and umbilical cord blood transplantation. Be The Match will use the provided funds to create and promote The Jason Carter Clinical Trials Program, which will help blood cancer patients identify and enroll in clinical trials more efficiently.

Studies show that patients on clinical trials have better outcomes than those who do not participate, but several enrollment barriers exist that prevent patients from participating.

The Carter family knows these barriers intimately and is dedicated to helping other patients navigate the opportunities to join clinical trials. Their son and brother, Jason Carter, battled leukemia for 4 ¼ years until he passed away at the age of 28 in May 2016. Jason's journey was challenging, but his participation in two clinical trials extended his life, gave him more time with his family and provided his best chance for a cure.

The family's extensive search for clinical trials exposed critical needs in the process. This new program, created in his name, will provide the following resources to support patients and their families:

  1. Centralized resource website where patients will learn about clinical trials, including a suite of multimedia tools and a searchable system with summary snapshots to find relevant trials.

  2. Clinical trials education specialist to provide one-on-one support for patients and families who have questions as they navigate the site.

  3. Physician awareness and education will be included because many patients depend solely on their doctor to advise them about potential treatment options, including clinical trials.

  4. Outreach and promotion for the three initiatives described above so people will find the resources and to extend our reach to impact more patients, families and physicians.

"We hoped Jason would live long enough to find a cure. He had an indomitable will to live and to beat his disease. He tried every new treatment and new therapy possible. It was still not enough. Only 5 percent of cancer patients take part in clinical trials. That number must greatly increase for outcomes to improve more quickly," said Jason's parents, Robert and Diana Carter. "Jason wanted to make a difference. The Jason Carter Clinical Trials Program will bring a greater transparency to opportunities that exist for patients and better inform their families of requirements for participation. We are thrilled to partner with Be The Match to improve this process and help other patients find the best treatment resources available. Together, we can help save lives."

"This donation from the Carter family will have a profound impact on patients and families for years to come," said Joy King, Senior Vice President of Philanthropy and Executive Director for Be The Match Foundation. "We could not be more honored and excited to carry out Jason's legacy through this new program. We sincerely thank the Carter family for their generosity and compassion for all patients."
About Be The Match Foundation®

Be The Match Foundation® raises funds to help provide marrow and umbilical cord blood transplants to patients with life-threatening blood cancers--like leukemia and lymphoma--or other diseases. With the public's help, the foundation gives patients a reason to hope and the power to heal. Foundation funds deliver tangible relief to patient families struggling with uninsured transplant costs, help add more potential marrow donors to Be The Match Registry® and support new research discoveries.

Be The Match® is operated by the National Marrow Donor Program® (NMDP), a nonprofit organization that matches patients with donors, educates health care professionals and conducts research so more lives can be saved.

To support the cure, visit or call 1 (800) 507-5427.


Related Bone Marrow Articles:

Researchers reveal developmental mechanisms behind rare bone marrow disorder
Myelodysplastic syndrome is an umbrella term used to describe disorders characterized by the bone marrow's inability to produce normal blood cells.
Researchers propose noninvasive method to detect bone marrow cancer
For the first time, researchers have shown that using magnetic resonance imaging can effectively identify bone marrow cancer (myelofibrosis) in an experimental model.
Bone marrow inflammation predicts leukemia risk
Cancer is generally thought to arise from genetic damage within individual cells, but recent evidence has suggested that abnormal signaling in the surrounding tissue also plays an important role.
New approach could make bone marrow transplants safer
Bone marrow transplantation is the only curative therapy for the millions of people living with blood disorders like sickle cell anemia, thalassemia, and AIDS.
Bone marrow lesions can help predict rapidly progressing joint disease
A new study from the Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, shows lesions, which can best be seen on MRI scans, could help identify individuals who are more likely to suffer from more rapidly progressing osteoarthritis.
Fat cells originating from bone marrow found in humans
Researchers at the University of Colorado Anschutz Medical Campus have found that fat cells produced by stem cells from the bone marrow may be linked to chronic illnesses like diabetes, cardiovascular disease, kidney disease and some cancers.
Zebrafish reveal drugs that may improve bone marrow transplant
Using large-scale zebrafish drug-screening models, researchers at Boston Children's Hospital have identified a potent group of chemicals that helps bone marrow transplants engraft or 'take.'
The secrets of bone marrow: What leads to healthy blood cell production?
The Medical College of Wisconsin has received a five-year, $635,000 grant from the National Institutes of Health's National Heart, Lung and Blood Institute to identify new potential treatments for diseases that inhibit the growth of blood cells and diseases in which the blood cells develop abnormally.
Clinical trial uses patients' own cells for treatment after bone marrow transplant
A clinical trial using personalized cellular therapy has begun enrolling children and adults suffering from graft-versus-host-disease, a life-threatening complication of bone marrow transplantation in which donor immune lymphocytes attack the organs of the bone marrow transplant recipient.
3-D engineered bone marrow makes functioning platelets
An international research team has reported development of the first three-dimensional tissue system that reproduces the complex structure and physiology of human bone marrow and successfully generates functional human platelets.

Related Bone Marrow Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...